M
Ming-Che Liu
Researcher at Taipei Medical University Hospital
Publications - 2
Citations - 63
Ming-Che Liu is an academic researcher from Taipei Medical University Hospital. The author has contributed to research in topics: Tolerability & Placebo. The author has an hindex of 1, co-authored 2 publications receiving 2 citations. Previous affiliations of Ming-Che Liu include Taipei Medical University.
Papers
More filters
Journal ArticleDOI
Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan.
Szu-Min Hsieh,Ming-Che Liu,Ming-Che Liu,Yen-Hsu Chen,Wen Sen Lee,Shinn-Jang Hwang,Shu-Hsing Cheng,Shu-Hsing Cheng,Wen Chien Ko,Kao-Pin Hwang,Ning-Chi Wang,Yu-Lin Lee,Yi-Ling Lin,Shin-Ru Shih,Chung-Guei Huang,Chung-Guei Huang,Chun-Che Liao,Jian-Jong Liang,C. S. Chang,Charles Chen,Chia En Lien,I-Chen Tai,Tzou Yien Lin,Tzou Yien Lin +23 more
TL;DR: In this article, the interim safety, tolerability, and immunogenicity results of a phase 2 clinical trial of the MVC-COV1901 vaccine in Taiwan were presented.
Posted ContentDOI
Safety and Immunogenicity of CpG 1018 and Aluminium Hydroxide-Adjuvanted SARS-CoV-2 S-2P Protein Vaccine MVC-COV1901: A Large-Scale Double-Blinded, Randomised, Placebo-Controlled Phase 2 Trial
Szu-Min Hsieh,Ming-Che Liu,Ming-Che Liu,Yen-Hsu Chen,Wen Sen Lee,Shinn-Jang Hwang,Shu-Hsing Cheng,Shu-Hsing Cheng,Wen Chien Ko,Kao-Pin Hwang,Ning-Chi Wang,Yu-Lin Lee,Yi-Ling Lin,Shin-Ru Shih,Chung-Guei Huang,Chung-Guei Huang,Chun-Che Liao,Jian-Jong Liang,C. S. Chang,Charles Chen,Chia En Lien,I-Chen Tai,Tzou Yien Lin,Tzou Yien Lin +23 more
TL;DR: MVC-COV1901 shows good safety profiles and promising immunogenicity responses and is supported to enter phase 3 efficacy trials and could enable regulatory considerations for Emergency Use Authorisation (EUA).